You are here: Industry Insights > clinical development

News List

BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development b3cnewswire
September 01, 2020
BioVersys announces the successful completion of a CHF 19 million Series B financing round to advance its two lead assets of infectious disease candidates into first in human clinical trials and has also strengthened its board with the appointment of Dr.
GT Biopharma Provides GTB-1550 Clinical Development Update americanpharmaceuticalreview
May 31, 2019
GT Biopharma has provided an update with respect to the further clinical development of GTB-1550.
WuXi AppTec to enhance biometrics services for clinical development biospectrumasia
May 06, 2019
Pharmapace will become a wholly-owned subsidiary of WuXi Clinical
ICT Opens US Office & Announces Executive Appointments contractpharma
March 08, 2019
Office to launch in Rockville, Maryland, with the new hires heading regulatory affairs, business development, and quality assurance.
LogicBio Therapeutics Appoints Kenneth Huttner, M.D., Ph.D., as Senior Vice President, Head of Clinical Development firstwordpharma
February 24, 2019
LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, today announced the appointment of Kenneth Huttner, M.D., Ph.D., as Senior Vice President, Head of Clinical Development.
Exelixis’ Cabometyx approved in second-line liver cancer in US pharmaphorum
January 16, 2019
Exelixis’ cancer drug Cabometyx has been approved in a new liver cancer use in the US, providing a second line therapy option for patients previously treated with Bayer’s Nexavar.
Luye Pharma’s Shares Drop on Acquisition of Two Biological Antibodies firstwordpharma
December 25, 2018
Luye Pharma announced that it acquired the biological monoclonal antibodies, LY01011 and LY09004, from Shandong Boan Biological Technology for nearly $73 million, reported Investing.com.
Luye Pharma’s Shares Drop on Acquisition of Two Biological Antibodies firstwordpharma
December 25, 2018
Luye Pharma announced that it acquired the biological monoclonal antibodies, LY01011 and LY09004, from Shandong Boan Biological Technology for nearly $73 million, reported Investing.com.
Alvotech, Fuji Pharma Expand Biosimilars Alliance contractpharma
December 19, 2018
Alvotech and Fuji Pharma have entered an exclusive agreement for the development and commercialization of biosimilars in Japan. Fuji is acquiring a 4.2% stake in Alvotech for approximately $50 million
AC Immune & Lilly Partner for Alzheimer's contractpharma
December 17, 2018
AC Immune SA and Eli Lilly and Company have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment

Previous page 1 2 Next page